Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |